Baricitinib 2mg and 4mg tablets
A Contract Award Notice
by NORTHERN HEALTH AND SOCIAL CARE TRUST
- Source
- Find a Tender
- Type
- Contract ()
- Duration
- not specified
- Value
- £1M
- Sector
- MISCELLANEOUS
- Published
- 14 Aug 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
1 buyer
1 supplier
- Lloyds Clinical Harlow
Description
The intended contract is for the supply of baricitinib tablets to Northern Health and Social Care Trust via homecare for a period of 3 years
Award Detail
1 | Lloyds Clinical (Harlow)
|
CPV Codes
- None found
Legal Justification
Purchase of drugs which are subject to patent protection/ Sole MA Holder, where no reasonable alternative or substitute exists. Section 41 schedule 5(5) of the PA2023 permits a direct award in the case of single supplier and permits the award if the following conditions are met in relations to the public contract - (a)due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods,services or works. These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-0587ac
- FTS 048656-2025